DE

590.14

+1.01%↑

FDX

391.46

+2.99%↑

CTAS

179.16

+0.92%↑

FAST

45.79

+2.39%↑

DAL

71.65

+2.39%↑

DE

590.14

+1.01%↑

FDX

391.46

+2.99%↑

CTAS

179.16

+0.92%↑

FAST

45.79

+2.39%↑

DAL

71.65

+2.39%↑

DE

590.14

+1.01%↑

FDX

391.46

+2.99%↑

CTAS

179.16

+0.92%↑

FAST

45.79

+2.39%↑

DAL

71.65

+2.39%↑

DE

590.14

+1.01%↑

FDX

391.46

+2.99%↑

CTAS

179.16

+0.92%↑

FAST

45.79

+2.39%↑

DAL

71.65

+2.39%↑

DE

590.14

+1.01%↑

FDX

391.46

+2.99%↑

CTAS

179.16

+0.92%↑

FAST

45.79

+2.39%↑

DAL

71.65

+2.39%↑

Search

Kadant Inc

Geschlossen

BrancheIndustrie

331.33 2.69

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

329.26

Max

339.74

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.7M

24M

Verkäufe

15M

286M

KGV

Branchendurchschnitt

37.912

55.46

Dividendenrendite

0.42

Gewinnspanne

8.394

Angestellte

3,900

EBITDA

-15M

54M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+2.91% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.42%

2.19%

Nächstes Ergebnis

28. Apr. 2026

Nächste Dividendenausschüttung

13. Mai 2026

Nächstes Ex-Dividendendatum

9. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-62M

3.9B

Vorheriger Eröffnungskurs

328.64

Vorheriger Schlusskurs

331.33

Nachrichtenstimmung

By Acuity

37%

63%

132 / 404 Ranking in Industrials

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Kadant Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Apr. 2026, 20:26 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17. Apr. 2026, 18:15 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17. Apr. 2026, 16:49 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17. Apr. 2026, 16:49 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17. Apr. 2026, 22:58 UTC

Ergebnisse

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17. Apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17. Apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17. Apr. 2026, 20:52 UTC

Ergebnisse

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17. Apr. 2026, 20:50 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

17. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Apr. 2026, 20:29 UTC

Ergebnisse

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17. Apr. 2026, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Buy Neurona Therapeutics for Up to $1.15B

17. Apr. 2026, 19:34 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

17. Apr. 2026, 19:34 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17. Apr. 2026, 19:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17. Apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17. Apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17. Apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17. Apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17. Apr. 2026, 18:57 UTC

Wichtige Nachrichtenereignisse

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17. Apr. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17. Apr. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

UCB 2026 Rev Guidance Unchanged

17. Apr. 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17. Apr. 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17. Apr. 2026, 18:14 UTC

Market Talk
Wichtige Nachrichtenereignisse

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17. Apr. 2026, 18:00 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17. Apr. 2026, 18:00 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17. Apr. 2026, 17:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17. Apr. 2026, 17:26 UTC

Market Talk
Ergebnisse

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Peer-Vergleich

Kursveränderung

Kadant Inc Prognose

Kursziel

By TipRanks

2.91% Vorteil

12-Monats-Prognose

Durchschnitt 341.5 USD  2.91%

Hoch 380 USD

Tief 303 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Kadant Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

293.2 / 303.41Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

132 / 404 Ranking in Industrie

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Kadant Inc

Kadant Inc. supplies technologies and engineered systems worldwide. It operates in three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems and equipment, such as rotary joints, syphons, turbulator bars, expansion joints, and engineered steam and condensate systems; and doctoring, cleaning, and filtration systems and related consumables consisting of doctor systems and holders, doctor blades, cleaning shower and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems. The Industrial Processing segment develops, manufactures, and markets ring and rotary debarkers, stranders, chippers, engineered knife systems, industrial automation and control, recycling and approach flow systems, and virgin pulping process equipment for use in the packaging, tissue, wood products, and alternative fuel industries. The Material Handling segment offers conveying and vibratory equipment, and baling products; and manufactures and sells biodegradable absorbent granules for carriers in agricultural, home lawn and garden, professional lawn, turf, and ornamental applications, as well as for oil and grease absorption. The company markets and sells its products, services, and systems through direct sales, independent sales agents, and distributors. The company was formerly known as Thermo Fibertek, Inc. and changed its name to Kadant Inc. in July 2001. Kadant Inc. was incorporated in 1991 and is headquartered in Westford, Massachusetts.
help-icon Live chat